Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pomalyst

  • Presage, Celgene Put Heads Together to Find New Cancer Drug Combos
    combinations itself: the FDA recently approved the company's application to market Pomalyst (pomalidomide) for relapsed and refractory multiple myeloma (MM) patients who did not ...
    3-5-2013
  • FDA Blocks Novo, Boosts Celgene
    ... Celgene Wins Pomalyst OK Celgene said the agency approved the company's application to market the Pomalyst (pomalidomide) for relapsed and refractory multiple myeloma (MM) patients ...
    2-11-2013

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll